CoreCap Advisors’s Celularity CELU Stock Holding History

CoreCap Advisors’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$675	Hold	500	–	–	﹤0.01%	2739
2026 Q2	$299	Hold	500	–	–	﹤0.01%	2947
2026 Q1	$665	Hold	500	–	–	﹤0.01%	2604
2025 Q4	$555	Hold	500	–	–	﹤0.01%	2690
2025 Q3	$1.04K	Hold	500	–	–	﹤0.01%	2479
2025 Q2	$980	Hold	500	–	–	﹤0.01%	2421
2025 Q1	$865	Hold	500	–	–	﹤0.01%	2556
2024 Q4	$1.04K	Hold	500	–	–	﹤0.01%	2369
2024 Q3	$1.48K	Buy	+500	New	+$1.47K	﹤0.01%	2222
2024 Q2	–	Sell	-500	Closed	-$2.62K	–	1762
2024 Q1	$2.62K	Buy	+500	New	+$2.06K	﹤0.01%	2066

Other funds holding CELU

Biltmore Family Office Charlotte, North Carolina $752M AUM 22.25% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Sky Investment Group Hartford, Connecticut $931M AUM 17.48% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $704M AUM 30.39% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Financial Perspectives Minneapolis, Minnesota $431M AUM 20.51% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return

United Financial Planning Group Hauppauge, New York $199M AUM 14.18% 1-Year Est. Return

CoreCap Advisors's CELU Position: Q3 2026 in Review

CoreCap Advisors held its Celularity (CELU) position steady in Q3 2026 at 500 shares worth $675. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

CoreCap Advisors first reported a position in CELU in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.62K in Q1 2024. 9 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

CoreCap Advisors held 500 shares of Celularity worth $675 as of Q3 2026.
CoreCap Advisors left its Celularity share count unchanged in Q3 2026.
Celularity made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2739 holding.
CoreCap Advisors first reported a position in Celularity in Q1 2024 and has held it in 10 quarters since.
CoreCap Advisors's Celularity position peaked at $2.62K in Q1 2024.
9 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.